Topics, Trends & Updates

December 2024

View as web page

Facebook  Twitter  Linkedin  Instagram  

Dr. Jason Zucker Receives the 32nd Annual Linda Laubenstein Clinical Excellence Award

Congratulations Dr. Zucker!


The 32nd annual Linda Laubenstein award recognizes Dr. Jason Zucker for his leadership in and unwavering commitment to providing clinical education on sexual health, mpox, and HIV prevention. His work has greatly expanded awareness on these topics among New York State care providers. 


Dr. Zucker is an Assistant Professor of Medicine in the Division of Infectious Diseases at Columbia University Medical Center and Assistant Medical Director of the New York City STD Prevention Training Center. He is a trained adult and pediatric infectious diseases physician experienced in providing high-quality, status-neutral HIV and sexual health care to patients of all ages in the NewYork-Presbyterian/Columbia Comprehensive Health Program Sexual Health Clinic.


Dr. Zucker serves as a consultant to the Centers for Disease Control and Prevention (CDC) and leads multiple National Institutes of Health (NIH)-funded studies. His crucial research focuses on using data, behavioral, and implementation science to enhance engagement in sexual health care for individuals living with or at risk of sexually transmitted infections (STIs). He coauthored the New York State Department of Health AIDS Institute (NYSDOH AI) clinical guidance Questions, Answers, and Best Practices for Expedited Partner Therapy (EPT), which informs clinicians about existing regulations that allow expedited treatment of sex partners of individuals diagnosed with gonorrhea, chlamydia, or trichomoniasis, and he is a key member in the New York State Congenital Syphilis Elimination Strategic Planning Group. 


Since the start of the 2022 mpox outbreak, Dr. Zucker has been actively involved in the mpox response. He again shared his expertise with the NYSDOH AI by coauthoring the clinical practice guideline Prevention and Treatment of Mpox, which provides evidence-based recommendations on primary prevention, diagnostic testing, and supportive care and treatment of mpox. Dr. Zucker serves as co-vice chair of the NIH-funded Tecovirimat for Human Monkeypox Virus (STOMP) study and co-investigator for the CDC-funded Life after Mpox (LAMP) study. He also serves on the CDC Advisory Committee on Immunization Practices for Mpox Working Group and the writing team for the mpox section of the NIH Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents With HIV.


For his passion, expertise, and steadfast commitment to serving the people of New York State and beyond, and for his contribution to the advancement of sexual health and well-being, we are delighted to recognize Dr. Zucker with the 2024 Linda Laubenstein award.

Updated Guideline: Laboratory Monitoring for Adverse Effects of ART

Updated by lead author Dr. Shauna Gunaratne, with the Medical Care Criteria Committee, the Laboratory Monitoring for Adverse Effects of ART guideline aims to inform clinicians about the range of adverse effects and toxicities associated with antiretroviral therapy (ART) and assist them in determining the frequency of routine laboratory monitoring.


Updates to the guideline include:


  • Long-acting injectable forms of ART
  • Discussion of weight gain and diabetes mellitus risk associated with certain ART regimens
  • Citations and references throughout the guideline


Go to the guideline

Contents:


Hot Topics


See all Hot Topics

Don't Miss

Updated Guideline: Perioperative Care in Adults With HIV


Updated Guideline: Prevention and Management of Hepatitis B Virus Infection in Adults With HIV


Updated Guideline: Doxycycline-PEP to Prevent Bacterial STIs


Conversations With CEI Podcast

Reflections from the 2024 CDC STI Prevention Conference: For the first time since 2018 and since the COVID-19 pandemic, the Centers for Disease Control and Prevention hosted their biennial STI Prevention Conference in person in Atlanta, GA, from September 16–19, 2024. This event brought together international leading researchers with government experts, clinical sexual healthcare providers, and state and local public health administrators for 4 days of scientific updates and sessions on science, programs, and policies related to STI care.


Dr. Marguerite Urban and Dr. Daniela DiMarco from the CEI Sexual Health Center of Excellence attended the conference and are back to bring you insights about their experience at the event. They chat about the different sessions they attended and share personal thoughts and summaries of the cutting-edge research presented at the conference, focusing on syphilis, Doxy-PEP, gonococcal resistance, and the syndemic of substance use and STIs. Listen Now

Upcoming Training, Education, and Events

CEI:

See all


General:

See all

Are You a Subscriber?



If this newsletter was forwarded to you, please subscribe now to make sure you receive the Clinical Guidelines Program Topics, Trends, and Updates newsletter every month and stay current with new and updated guidelines. We send 1 email per month and do not share our mailing list.

Comments? Questions? Suggestions?


Email us: aiguidelines@jhmi.edu. 

We'll get back to you as quickly as possible.


Note that we cannot answer questions about the care or treatment of specific patients and cannot provide clinical advice.